Mapping the hospital ecosystem: who holds the cards

3. Payers (the health plans)

Payers are who actually pays the bills: commercial insurers (UnitedHealthcare, Elevance, Cigna, Aetna/CVS), and government programs. In the US, Medicare (federal, for people 65+) and Medicaid (federal plus state, for low-income patients) together account for a large share of most hospitals' volume.

The power move here: Medicare and Medicaid set prices administratively. The hospital cannot negotiate them. It takes the published rate or stops treating those patients. Commercial insurers, by contrast, negotiate, and that is where the real fight over margin happens.

In Europe the picture differs sharply. In the UK, the National Health Service (NHS) is both payer and provider. In Germany, statutory health insurance funds ("Krankenkassen") negotiate within a tightly regulated framework. The lesson: the more concentrated the payer, the less pricing power the hospital has.

4. Suppliers (the makers of the stuff)

Two groups matter most:

• Medical device and supply makers: Medtronic, Johnson & Johnson MedTech, Stryker, Boston Scientific, Becton Dickinson. Some hold near-monopolies on specific implants or devices, which gives them strong pricing power.
• Pharmaceutical manufacturers: for the drugs administered in hospitals.

A cardiac surgeon may insist on one manufacturer's heart valve. That "physician preference item" hands the supplier real power, because the hospital cannot simply switch to a cheaper substitute without a clinical fight.

5. Distributors and GPOs (the middlemen)

Two different roles, often confused:

• Distributors physically move product from manufacturer to hospital loading dock. The big three in US medical-surgical distribution are Cardinal Health, McKesson, and Owens & Minor. They earn a margin on logistics.
• Group Purchasing Organizations (GPOs) do not move anything. They aggregate the purchasing volume of many hospitals to negotiate lower prices with manufacturers. The largest US GPOs are Vizient, Premier, and HealthTrust. Most US hospitals buy the bulk of their supplies through GPO contracts.

Back to our suture: the GPO negotiated the price using pooled volume, the distributor delivered it, the manufacturer made it. The hospital just executed a pre-set contract.

For a solid free primer on how these intermediaries fit together, see the Health Affairs Health Policy Briefs.

6. Regulators (the rule-setters)

Regulators shape what everyone else can do:

• CMS (Centers for Medicare & Medicaid Services): sets Medicare/Medicaid payment rates and conditions of participation. The single most powerful US regulator for hospital economics.
• FDA (Food and Drug Administration): approves drugs and devices.
• The Joint Commission: accredits hospitals; losing accreditation can cut off Medicare payment.
• FTC (Federal Trade Commission) and DOJ: review hospital mergers for antitrust concerns.
• State Certificate of Need (CON) laws: in many US states, a hospital must get state permission before adding beds or buying a big scanner. This protects incumbents from new competition.

In Europe, add national bodies: England's Care Quality Commission, Germany's Federal Joint Committee (G-BA), and country-level pricing authorities.

Where the power actually sits

Here is the counterintuitive core of the module. Power flows to whoever is scarce or concentrated, not to whoever holds the patient.

• The dominant neighbor holds cards because of market sharemarket shareThe percentage of total industry sales your company captures in a given period. It measures competitive position relative to rivals in a defined market.Voir la définition complète → in a region.
• The payer holds cards because it controls the flow of patients and dollars.
• The device maker holds cards because of clinical irreplaceability.
• The GPO holds cards because of aggregated volume.
• CMS holds cards because it can simply set the price.

Our 400-bed hospital, sitting in the middle, is a price-taker on most fronts. Its leverage comes from three things: local reputation, physician relationships, and being large enough that an insurer wants it in-network.

How the dollar splits: a worked example

Let us trace revenue on a single knee replacement to see how margin distributes. These are illustrative round numbers, not actual prices, used to show the mechanics.

Assume the commercial insurer reimburses the hospital $30,000 for the full episode.

• Implant (device maker, via GPO contract): $6,000
• Other supplies and drugs (via distributor): $1,500
• Surgeon and anesthesia (often billed separately, but assume employed): $4,000
• Nursing, OR time, facility overhead: $14,000
• Remaining operating margin to the hospital: $4,500

Now watch what each player controls:

• The device maker captured $6,000 and set that price with little hospital input.
• The GPO shaved perhaps 10 to 15 percent off the implant list price, invisible to the patient.
• The insurer set the $30,000 ceiling. If it had negotiated $27,000 instead, the hospital's $4,500 margin nearly vanishes.

The lesson in numbers: the hospital's margin is the residual. It is what is left after players with more leverage take their cut. A small shift in the insurer rate or the implant price swings hospital profitability far more than anything the hospital does operationally.

Competitive dynamics: how the mapmapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.Voir la définition complète → is changing in 2026

Three forces are redrawing the ecosystem:

Consolidation, everywhere. Hospitals merge into bigger systems to gain insurer leverage. Insurers merge and buy providers. The clearest example: UnitedHealth Group's Optum arm now employs or affiliates with tens of thousands of physicians, making a payer also a provider. When your insurer owns the doctors, the traditional payer-versus-provider line blurs.

Vertical integration by outsiders. CVS Health (owns Aetna) and Optum are building care delivery outside the hospital. Ambulatory surgery centers (ASCs), freestanding facilities that do outpatient surgery, siphon the profitable, low-complexity procedures away from hospitals, leaving hospitals with sicker, costlier cases.

Site-of-care shift. Payers increasingly refuse to pay hospital prices for procedures that can be done in a cheaper ASC or at home. This directly attacks the high-margin outpatient business hospitals rely on to subsidize money-losing services like emergency care.

The strategic takeaway for our 400-bed system: its biggest threat may not be the hospital next door. It may be an insurer-owned clinic, an ASC joint venture, and a payer refusing to send patients through its doors at all.

Reading any hospital market fast

When you assess a new hospital market, ask five questions in order:

1. How concentrated are the hospitals? One dominant system means everyone else is a price-taker.

2. How concentrated are the payers? A single dominant insurer flips the leverage back to the payer.

3. Which suppliers are irreplaceable? Physician preference items signal supplier power.

4. Which GPO does the hospital use, and what share of spend runs through it?

5. What is the regulatory frame? CON laws, merger scrutiny, and CMS rate changes reshape everything.

Key Takeaways

• The payer is not the patient, and the payer holds the cards. In the US, CMS sets prices administratively; commercial insurers negotiate them. Payer concentration is the single biggest driver of hospital pricing power.
• The hospital's margin is a residual. It is what remains after device makers, distributors, and clinicians take their slices, all capped by the insurer's negotiated rate.
• GPOs, not hospitals, set most supply prices. Understand the difference: GPOs negotiate on pooled volume; distributors move product; manufacturers make it.
• Regional market share is the incumbent's main weapon. A "must-have" system extracts higher rates simply by being un-excludable from insurer networks.
• The real 2026 threat is vertical, not lateral. Insurer-owned clinics, ASCs, and site-of-care shifts pull profitable volume away before it ever reaches the hospital.